[Radionuclide studies in chronically hemodialyzed patients. Bone scintigraphy for the evaluation and control of renal osteopathy].
The clinical applicability of bone scintigraphy (Tc99m MDP) was evaluated in 42 patients on maintenance hemodialysis. Typical scintigraphic findings are shown which were related to hormonal and biochemical parameters of calcium and phosphate metabolism. Visual grading of representative regions for metabolic bone disease in bone scans was compared to scintimetry which applies a bone to soft tissue ratio to grade osseous abnormalities. It could be shown that visual interpretation and grading of the findings according to a score is sufficient to assess the degree and extent of renal bone disease. Semiquantitative analysis of bone scintigrams by scintimetry did not improve the diagnostic information.
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000378:metabolism; D001842:Bone and Bones / Q000000981:diagnostic imaging*; D002118:Calcium / Q000097:blood; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000175:diagnosis*; D004164:Diphosphonates; D005260:Female; D006225:Hand / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D008334:Mandible / Q000000981:diagnostic imaging; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000032:analysis; D011877:Radionuclide Imaging; D006435:Renal Dialysis / Q000009:adverse effects*; D013667:Technetium; D013669:Technetium Tc 99m Medronate
D004164:Diphosphonates; D010281:Parathyroid Hormone; D013667:Technetium; D000469:Alkaline Phosphatase; D002118:Calcium; D013669:Technetium Tc 99m Medronate
Nuklearmedizinische Untersuchungen bei chronisch hämodialysierten Patienten. Skelettszintigraphie zur Beurteilung und Uberwachung der renalen Osteopathie.